Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Hikma Pharmaceuticals Fundamentals

Company Name Hikma Pharmaceuticals Last Updated 21 May 2020
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 242.54 Market Cap (£m) 6,099.97
PE Ratio 12.53 Div per Share (c) 44.00
Div Yield 1.43 Div Cover 4.56
EPS 200.80 EPS Growth (%) 71.62
PEG 0.17 DPS Growth (%) 15.79
Debt Ratio 13.42 Debt Equity Ratio 0.18
Net Gearing 34.58 Gross Gearing 45.83
Asset Equity Ratio 1.85 Cash Equity Ratio 20.76
Quick Ratio 0.87 Current Ratio 1.26
Price To Book Value 2.87 ROCE 19.97

Hikma Pharmaceuticals Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
H2 Dividend 19 Mar 2020 07 May 2020 USX 30.00 44.00
H1 Dividend 22 Aug 2019 23 Sep 2019 USX 14.00
H2 Dividend 04 Apr 2019 22 May 2019 USX 26.00 38.00
H1 Dividend 23 Aug 2018 21 Sep 2018 USX 12.00
H2 Dividend 05 Apr 2018 24 May 2018 USX 23.00 34.00
H1 Dividend 24 Aug 2017 22 Sep 2017 USX 11.00
H2 Dividend 06 Apr 2017 25 May 2017 USX 22.00 33.00
H1 Dividend 01 Sep 2016 30 Sep 2016 USX 11.00
H2 Dividend 07 Apr 2016 19 May 2016 USX 21.00 32.00
H1 Dividend 27 Aug 2015 25 Sep 2015 USX 11.00

Hikma Pharmaceuticals Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 912 870 828
Intangible Assets 834 766 785
Investments 336 193 201
Total Fixed Assets 2,082 1,829 1,814
Stocks 568 528 488
Debtors 719 731 707
Cash & Equivalents 442 276 227
Other Assets 119 133 152
Total Assets 3,930 3,497 3,388
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 1,471 893 797
Creditors after 1 year 330 907 1,063
Other Liabilities 0 0 0
Total Liabilities 1,801 1,800 1,860
Net assets 2,129 1,697 1,528
Equity (£m) 2019 2018 2017
Called up share capital 41 40 40
Share Premium 282 282 282
Profit / Loss 491 293 -738
Other Equity -179 -217 1,192
Preference & Minorities 12 12 14
Total Capital Employed 2,129 1,697 1,528
Ratios 2019 2018 2017
Debt Ratio 13.42 34.83 41.03
Debt-to-Equity 0.18 0.50 0.57
Net Gearing 34.58 43.58 48.20
Gross Gearing 45.83 51.47 54.90
Assets / Equity 1.85 2.06 2.22
Cash / Equity 20.76 16.26 14.86
EPS 200.80 117.00 -351.80
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 472 430 443
Cashflow before financing 321 334 292
Increase in Cash 166 56 72
Income (£m) 2019 2018 2017
Turnover 2,207 2,070 1,936
Cost of sales 1,059 1,020 969
Gross Profit 1,148 1,050 967
Operating Profit 493 371 -747
Pre-Tax profit 491 293 -738
Profit / Loss for the year 41 40 40

Hikma Pharmaceuticals Company Background

Sector Pharmaceuticals
Activities Hikma Pharmaceuticals plc principal activities are the development, manufacture, and marketing of a broad range of branded and non-branded generic pharmaceuticals products across the US, the Middle East and North Africa (MENA) and Europe. Hikma is also a leading licensing partner in MENA.
Latest Interim Date 09 Aug 2019
Latest Fiscal Year End Date 27 Feb 2020

Hikma Pharmaceuticals Directors

Appointed Director Position
20 Feb 2018 Sigurdur Oli Olafsson Chief Executive Officer
01 Jul 2007 Said Samih Darwazah Executive Chairman
01 Nov 2005 Mazen Samih Darwazah Executive Vice Chairman
01 May 2020 Douglas Malcolm Hurt Non-Executive Director
01 Apr 2014 Patrick Noel Butler Non-Executive Director
01 Mar 2016 John Julius Castellani Non-Executive Director
01 Nov 2005 Ali Mohammed Al-Husry Non-Executive Director
01 Jun 2019 Cynthia Louise Schwalm Non-Executive Director
01 Sep 2011 Robert Mark Pickering Non-Executive Director
01 Dec 2014 Dr Pamela Josephine Kirby Non-Executive Director
01 Oct 2016 Mary Regina Henderson Non-Executive Director
24 Dec 2015 Dr Jochen Gann Non-Executive Director

Hikma Pharmaceuticals Contact Details

Company Name Hikma Pharmaceuticals
Company Address 13 Hanover Square, London W1S 1HL.
Company Telephone +44 (0)20 7399 2760
Company Website http://www.hikma.com/

Hikma Pharmaceuticals Advisors

Auditor Name Deloitte & Touche LLP
Auditor Address 2 New Street Square, London EC4A 3BZ.
Auditor Website http://www.deloitte.com/
Auditor Telephone +44 (0)20 7936 3000
Registrar Name Link Asset Services
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.linkassetservices.com/
Registrar Telephone 0870 162 3100
Broker Name Citigroup Global Markets
Broker Address Citigroup Centre, 33 Canada Square, Canary Wharf, London E14 5LB.
Broker Website http://www.citi.com/
Broker Telephone +44 (0)20 7986 4000
Adviser Name n/a
Adviser Address n/a
Adviser Website n/a
Adviser Telephone n/a
Solicitor Name Ashurst LLP
Solicitor Address Broadwalk House, 5 Appold Street, London EC2A 2HA.
Solicitor Website http://www.ashurst.com/
Solicitor Telephone +44 (0)20 7638 1111
Stockbroker Name Merrill Lynch International
Stockbroker Address Merrill Lynch Financial Centre, 2 King Edward Street, London, EC1A 1HQ.
Stockbroker Website http://www.ml.com/
Stockbroker Telephone +44 (0)20 7628 1000